Apparent skeletal muscle loss related to dietary trans fatty acids in a mixed group of omnivores and vegetarians

Nutrition Research

Volumn 23, Issue 5, 2003, Pages 651-658

  Hubbard, Richard ^a   Westengard, James ^a   Sanchez, Albert ^b   Homing, Merritt ^c   Barth, Jacques ^d  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Pacific Health Education Center   (United States)

^c Lassen Foundation   (United States)

^d Prevention Concepts   (United States)

Author keywords

Alanine; Isoleucine; Mead's acid; Skeletal muscle loss; Trans linoleic acid

Indexed keywords

5,8,11 ICOSATRIENOIC ACID; ALANINE; FATTY ACID; GLYCINE; ISOLEUCINE; LEUCINE; LINOLEIC ACID; LYSINE; PROSTAGLANDIN;

ADULT; AGED; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; AMINO ACID URINE LEVEL; ARTICLE; CHIRALITY; CONTROLLED STUDY; CORRELATION ANALYSIS; FATTY ACID ANALYSIS; FEMALE; FOOD COMPOSITION; HEALTH HAZARD; HUMAN; HUMAN EXPERIMENT; MALE; MUSCLE ATROPHY; NORMAL HUMAN; OMNIVORY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN INTAKE; PROTEIN METABOLISM; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; REGRESSION ANALYSIS; SKELETAL MUSCLE; VEGETARIAN;

EID: 0037569531     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0271-5317(03)00026-5     Document Type: Article

References (36)

1. Hubbard RW, Westengard J, Sanchez A, Barth J. Chronic gluconeogenesis lowers urinary amino acids. Exp Biol 1999;13(5):935, #688.19.
2. Hubbard RW, Westengard J, Sanchez A, Barth J. Chronic gluconeogenesis with high lipid oxidation in a normal control population. Exp Biol 1999;13(5):935, #688.20.
3. Hubbard RW, Horning M. Daytime gluconeogenesis in the young and old apparently caused by essential fatty acid deficiency. Exp Biol 1997;11(3):A160, #935.
4. Chisholm A, Mann J, Skeaff M. Trans fatty acids: a cause for concern? Inter J Food Sci and Clin Nutr 1995;46:171-6.
5. Mann GV. Metabolic consequences of dietary trans fatty acids. Lancet 1994;343:1268-71.
6. Willett WC, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Rosner BA, Sampson LA, Hennekens CH. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 1993;341:581-5.
7. Bolton-Smith C, Woodward M, Fenton S, Brown CA. Does dietary trans fatty acid intake relate to the prevalence of coronary heart disease in Scotland? Eur Heart J 1996;17:837-45.
8. Mensink RP, Temme EHM, Homstra G. Dietary saturated and trans fatty acids and lipoprotein metabolism. Ann Med 1994;26:461-4.
9. Noakes M, Clifton PM. Oil blends containing partially hydrogenated or inter-esterified fats: differential effects on plasma lipids. Am J Clin Nutr 1998;68:242-7.
10. Nestel P, Noakes M, Belling B, McArthur R, Clifton P, Janus E, Abbey M. Plasma lipoprotein lipid and Lp(a) changes with substitution of elaidic acid for oleic in the diet. J Lipid Res 1992;33:1029-36.
11. Lichtenstein AH. Trans fatty acids and blood lipid levels, Lp(a), parameters of cholesterol metabolism, and hemostatic factors. Nutr Biochem 1998;9:244-8.
12. Koletzko B. Trans fatty acids may impair biosynthesis of long-chain polyunsaturates and growth in man. Acta Paediatr 1992;81:302-6.
13. Williams MA, King IB, Sorensen TK, Zinghein RW, Troyer BL, Zebelman AM, Luthy DA. Risk of preeclampsia in relation to elaidic acid trans fatty acid in maternal erythrocytes. Gynecol Obstet Invest 1998;46:84-7.
14. Chardigny JM, Sebedio JL, Grandgirard QA. Possible physiological effects of trans polyunsaturated fatty acids. Editors Sinclair A, Gibson R., Third International Congress of the American Oil Chemists Society, Champaign, Illinois 1992, pgs 148-52.
15. Booyens J, Van Der Merwe CF. Margarines and coronary artery disease. Med Hypothesis 1992;27:241-4.
16. Simopoulos AP. Omega-6/Omega-3 fatty acid ratio and trans fatty acids in non-insulin-dependent diabetes mellitus. Lipids and Syndromes of Insulin Resistance Annals of the New York Academy of Sciences 1997;827:327-38.
17. Sugano M, Ikeda I. Metabolic interactions between essential and trans-fatty acids. Curr Opin Lipidol 1996;7:38-42.
18. Hill EG, Johnson SB, Holman RT. Intensification of essential fatty acid deficiency in the rat by dietary trans fatty acids. J Nutr 1997;109:1759-65.
19. Allison DB, Egan K, Barraj LM, Caughman C, Infante M, Heimbach JT. Estimated intakes of trans fatty and other fatty acids in the US population. J Am Diet Assoc 1999;99:166-74.
20. Ratnayake WMN, Pelleltier G, Hollywood R, Bacler S, Leyte D. Trans fatty acids in Canadian margarines: recent trends. JAOCAS 1998;75:1587-94.
21. van Poppel G, on behalf of the Transfair Study Group. Intake of trans fatty acids in Western Europe: the Transfair study. Lancet 1998;351:1099.
22. Decsi T, Koletzko B. Do trans fatty acids impair linoleic acid metabolism in children? Ann Nutr Metab 1995;39:36-41.
23. Fulco AJ, Mead JF. Metabolism of essential fatty acids: VIII. Origin of 5,8,11-eisosatrienoic acid in the fat deficient rat. J Biol Chem 1959;234:1411-16.
24. Hubbard RW, Westengard J, Sanchez A. Trans-linoleic acid and its metabolic comparisons in an adult group of omnivores and vegans. Exp Biol 2002;16(5),A988, 727.10.
25. DeHoog S. The assessment of nutritional status. In: Mahan LK, Escott-Stump S, editors. Krause's Food Nutrition and Diet Therapy. New York: WB Saunders, 1996. p. 351-86.
26. Hubbard RW, Chambers JG, Sanchez A, Slocum R, Lee P. Amino acid analysis of plasma: studies in sample preparation. J Chrom 1988;431:163-9.
27. Shaw, K, Hubbard, RW. A cooperative plasma and urine amino acid reference range project between Children's Hospital of Los Angeles and Loma Linda University. Unpublished results 1987.
28. Moser A, Jones DS, Raymond GV, Moser HW. Plasma and red blood cell fatty acids in peroxisomal disorders. Neurochem Res 1999;24:187-96.
29. Raiten DJ. Introduction: Clinical trials for the treatment of secondary wasting and cachexia. J Nutr 1999;1229:223S-4S.
30. Yu YM, Yang RD, Matthews DE, Wen ZM, Burke JF, Bier DM, Young VR. Quantitative aspects of glycine and alanine nitrogen metabolism in post absorptive young men: effects of level of nitrogen and dispensable amino acid intake. J Nutr 1985;115:399-410.
31. Chevilotte E, Rieusset J, Roques M, Desage M, Vidal H. The regulation of uncoupling protein-2 gene expression by omega-6 polyunsaturated fatty acids in human skeletal muscle cells involves multiple pathways, including the nuclear receptor peroxisome proliferator-activated receptor beta. J Biol Chem 2001;276:10853-60.
32. Nakamura MT, Cho HP, Clarke SD. Regulation of hepatic delta-6-desaturase expression and its role in the polyunsaturated fatty acid inhibition of fatty acid synthase gene expression in mice. J Nutr 2000;130:1561-5.
33. Kersten S, Mandard S, Escher P, Gonzalez FJ, Tafuri S, Desvergne B, Wahli W. The peroxisome proliferators-activated receptor alpha regulates amino acid metabolism. FASEB J 2001;15:1971-8.
34. Jump DB, Clarke SD, Thelen A, Liimatta M. Coordinate regulation of glycolytic and lipogenic gene expression by polyunsaturated fatty acids. J Lipid Res 1994;35:1076-84.
35. Salmeron J, Hu FB, Manson JE, Stampfer MJ, Colditz GA, Rimm EB, Willet WC. Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 2001;73:1019-26.
36. Ozananne SE, Martensz ND, Petry CJ, Loizou CL, Hales CN. Maternal low protein diet in rats programmed fatty acid desaturase activities in the offspring. Diabetologia 1998;41:1337-42.